1 |
Alqahtani, A., Hamid, K., Kam, A., Wong, K. H., Abdelhak, Z., Razmovski-Naumovski, V., Chan, K., Li K. M., Groundwater, P. W. and Li, G. Q. 2013. The pentacyclic triterpenoids in herbal medicines and their pharmacological activities in diabetes and diabetic complications. Curr. Med. Chem. 20, 908-931.
DOI
|
2 |
Blahova, J., Martiniakova, M., Babikova, M., Kovacova, V., Mondockova, V. and Omelka, R. 2021. Pharmaceutical drugs and natural therapeutic products for the treatment of type 2 diabetes mellitus. Pharmaceuticals (Basel) 14, 806.
|
3 |
Ceriello, A., Hanefeld, M., Leiter, L., Monnier, L., Moses, A., Owens, D., Tajima, N. and Tuomilehto, J. 2004. Post-prandial glucose regulation and diabetic complications. Arch. Intern. Med. 164, 2090-2095.
DOI
|
4 |
Hanefeld, M. and Temelkova-Kurktschiev, T. 1997. The postprandial state and the risk of atherosclerosis. Diabet. Med. 14, S6-S11.
DOI
|
5 |
Li, Y., Wen, S., Kota, B. P., Peng, G., Li, G. Q., Yamahara, J. and Roufogalis, B. D. 2005. Punica granatum flower extract, a potent α-glucosidase inhibitor, improves post-prandial hyperglycemia in Zucker diabetic fatty rats. J. Ethnopharmacol. 99, 239-244.
DOI
|
6 |
Nathan, D. M., Meigs, J. and Singer, D. E. 1997. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is ... or is it? Lancet 350, SI4-SI9.
|
7 |
Ding, H., Wu, X., Pan, J., Hu, X., Gong, D. and Zhang, G. 2018. New insights into the inhibition mechanism of betulinic acid on α-glucosidase. J. Agric. Food. Chem. 66, 7065-7075.
DOI
|
8 |
Rajendran, P., Jaggi, M., Singh, M. K., Mukherjee, R. and Burman, A. C. 2008. Pharmacological evaluation of C-3 modified Betulinic acid derivatives with potent anticancer activity. Invest. New Drugs 26, 25-34.
DOI
|
9 |
Nazaruk, J. and Borzym-Kluczyk, M. 2015. The role of triterpenes in the management of diabetes mellitus and its complications. Phytochem. Rev. 14, 675-690.
DOI
|
10 |
O'Keefe, J. H. and Bell, D. S. 2007. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am. J. Cardiol. 100, 899-904.
DOI
|
11 |
Rosak, C. and Mertes, G. 2012. Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations. Diabetes Metab. Syndr. Obes. 5, 357.
|
12 |
Shaodan, C., Bing, L., Jiangyong G., Tianqiao, Y., Xiong, G., Yizhen, X., Chun, X., Janis, Y. Z. and Qingping W. 2022. Binding interaction of betulinic acid to α-glucosidase and its alleviation on postprandial hyperglycemia. Molecules 27, 2517
|
13 |
Song, T. J., Park, C. H., In, K. R., Kim, J. B., Kim, J. H., Kim, M. and Chang, H. J. 2021. Antidiabetic effects of betulinic acid mediated by the activation of the AMP-activated protein kinase pathway. PLoS One 16, e0249109.
|
14 |
Sperling, M. A. 2014. Diabetes mellitus. Pediatric Endocrinology, pp. 846-900, 4th ed., Philadelphia: Elsevier.
|
15 |
Tadera, K., Minami, Y., Takamatsu, K. and Matsuoka, T. 2006. Inhibition of α-glucosidase and α-amylase by flavonoids. J. Nutr. Sci. Vitaminol. 52, 149-153.
DOI
|
16 |
The IDF Diabetes Atlas. 10th edition. 2021. International Diabetes Federation.
|
17 |
Zhang, B. W., Xing, Y., Wen, C. Yu, X. X., Sun, W. L., Xiu, Z. L. and Dong, Y. S. 2017. Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: Structure-activity relationships and the synergism with acarbose. Bioorg. Med. Chem. Lett. 27, 5065-5070.
DOI
|
18 |
Wu, P. P., Zhang, K., Lu, Y. J., He, P. and Zhao, S. Q. 2014. In vitro and in vivo evaluation of the antidiabetic activity of ursolic acid derivatives. Eur. J. Med. Chem. 80, 502-508.
DOI
|
19 |
Watanabe, J., Kawabata, J., Kurihara, H. and Niki, R. 1997. Isolation and identification of alpha-glucosidase inhibitors from tochucha (Eucommia ulmoides). Biosci. Biotechnol. Biochem. 61, 77-178.
|
20 |
Xie, R., Zhang, H., Wang, X. Z., Yang, X. Z., Wu, S. N., Wang, H. G., Shen, P. and Ma, T. H. 2017. The protective effect of betulinic acid (BA) diabetic nephropathy on streptozotocin (STZ)-induced diabetic rats. Food Funct. 8, 299-306.
DOI
|
21 |
Shim, Y. J., Doo, H. K., Ahn, S. Y., Kim, Y. S., Seong, J. K., Park, I. S. and Min, B. H. 2003. Inhibitory effect of aqueous extract from the gall of Rhus chinensis on alpha-glucosidase activity and postprandial blood glucose. J. Ethnopharmacol. 85, 283-287.
DOI
|
22 |
Ceriello, A., Assaloni, R., Da Ros, R., Maier, A., Piconi, L., Quagliaro, L., Esposito, K. and Giugliano, D. 2005. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 111, 2518-2524
DOI
|
23 |
Gheorgheosu, D., Duicu, O., Dehelean, C., Soica, C. and Muntean, D. 2014. Betulinic acid as a potent and complex antitumor phytochemical: a minireview. Anticancer Agents Med. Chem. 14, 936-945.
DOI
|
24 |
Luna, B. and Feinglos, M. N. 2001. Oral agents in the management of type 2 diabetes mellitus. Am. Fam. Physician 63, 1747-1756.
|
25 |
Node, K. and Inoue, T. 2009. Postprandial hyperglycemia as an etiological factor in vascular failure. Cardiovasc. Diabetol 8, 23.
|
26 |
Rios, J. L. and Manez, S. 2018. New pharmacological opportunities for betulinic acid. Planta Med. 84, 8-19.
DOI
|
27 |
Tabatabaei-Malazy O., Larijani B. and Abdollahi M. 2015. Targeting metabolic disorders by natural products. J Diabetes Metab Disord. 14, 57.
|
28 |
Aiken, C. and Chen, C. H. 2005. Betulinic acid derivatives as HIV-1 antivirals. Trends Mol. Med. 11, 31-36.
DOI
|
29 |
Bhandari, M. R., Jong-Anurakkun, N., Hong, G. and Kawabata, J. 2008. α-Glucosidase and α-amylase inhibitory activities of Nepalese medicinal herb Pakhanbhed (Bergenia ciliata, Haw.). Food Chem. 1061, 247-252.
|
30 |
Birgani, G. A., Ahangarpour, A., Khorsandi, L. and Moghaddam, H. F. 2018. Anti-diabetic effect of betulinic acid on streptozotocin-nicotinamide induced diabetic male mouse model. Braz. J. Pharm. Sci. 54, e17171.
|
31 |
Ceriello, A. 2000. The post-prandial state and cardiovascular disease: relevance to diabetes mellitus. Diabetes Metab. Res. 16, 125-132.
DOI
|
32 |
Castellano, J. M., Guinda, A., Delgado, T., Rada, M. and Cayula, J. A. 2013. Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes. Diabete 62, 1791-1799.
DOI
|